SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'DIH'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JDV_A_ADNA1260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | PO4 A 501 (-2.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.50A | 1jdvA-3of3A:32.71jdvD-3of3A:32.7 | 1jdvA-3of3A:30.771jdvD-3of3A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JDV_B_ADNB2260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | PO4 A 501 (-2.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.51A | 1jdvB-3of3A:32.51jdvC-3of3A:33.0 | 1jdvB-3of3A:30.771jdvC-3of3A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JDV_D_ADND3260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | PO4 A 501 (-2.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.48A | 1jdvA-3of3A:32.71jdvD-3of3A:32.7 | 1jdvA-3of3A:30.771jdvD-3of3A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JDV_E_ADNE4260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 12 | ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.54A | 1jdvE-3of3A:32.61jdvF-3of3A:33.1 | 1jdvE-3of3A:30.771jdvF-3of3A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_A_ADNA1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | ARG A 101GLY A 191GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneNoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.26A | 1odiA-3of3A:25.9 | 1odiA-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_A_ADNA1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.43A | 1odiA-3of3A:25.9 | 1odiA-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_B_ADNB1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.45A | 1odiB-3of3A:35.3 | 1odiB-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_C_ADNC1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.41A | 1odiC-3of3A:35.6 | 1odiC-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_D_ADND1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.46A | 1odiD-3of3A:35.4 | 1odiD-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_E_ADNE1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.42A | 1odiE-3of3A:35.4 | 1odiE-3of3A:34.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ODI_F_ADNF1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.43A | 1odiF-3of3A:35.4 | 1odiF-3of3A:34.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PG2_A_ADNA552_1 (METHIONYL-TRNASYNTHETASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | GLU A 195GLY A 77HIS A 76TYR A 86VAL A 87 | DIH A 500 (-2.9A)NoneNoneNoneNone | 1.10A | 1pg2A-3of3A:undetectable | 1pg2A-3of3A:20.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK7_A_ADNA1245_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 9 | MET A 78ARG A 101SER A 104GLY A 106GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.53A | 1pk7A-3of3A:39.6 | 1pk7A-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK7_B_ADNB1246_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 8 | ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.56A | 1pk7B-3of3A:40.4 | 1pk7B-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK7_B_ADNB1246_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 8 | ARG A 101GLY A 191VAL A 192MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.38A | 1pk7B-3of3A:40.4 | 1pk7B-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 10 | ARG A 101GLY A 191VAL A 192MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.44A | 1pk7C-3of3A:22.1 | 1pk7C-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 10 / 10 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.27A | 1pk7C-3of3A:22.1 | 1pk7C-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK9_A_2FAA306_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.42A | 1pk9A-3of3A:39.9 | 1pk9A-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK9_A_2FAA306_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 10 / 10 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.37A | 1pk9A-3of3A:39.9 | 1pk9A-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK9_B_2FAB307_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 9 | ARG A 101GLY A 191GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneNoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.12A | 1pk9B-3of3A:40.2 | 1pk9B-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK9_B_2FAB307_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 9 | MET A 78ARG A 101SER A 104GLY A 106GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.40A | 1pk9B-3of3A:40.2 | 1pk9B-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PK9_C_2FAC308_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 11 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A)None | 0.27A | 1pk9C-3of3A:43.8 | 1pk9C-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PW7_A_RABA645_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 10 / 10 | MET A 78ARG A 101SER A 104GLY A 106GLU A 193MET A 194GLU A 195SER A 217ASP A 218ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A)None | 0.47A | 1pw7A-3of3A:39.9 | 1pw7A-3of3A:79.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PW7_B_RABB646_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 9 | ARG A 101GLY A 191VAL A 192MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.45A | 1pw7B-3of3A:40.8 | 1pw7B-3of3A:79.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PW7_B_RABB646_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 9 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.34A | 1pw7B-3of3A:40.8 | 1pw7B-3of3A:79.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PW7_C_RABC647_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 9 | MET A 78SER A 104VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 ( 2.7A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A)None | 0.37A | 1pw7C-3of3A:41.2 | 1pw7C-3of3A:79.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PWY_E_AC2E290_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 8 / 10 | GLY A 203PHE A 285GLU A 286GLY A 303MET A 304THR A 327ASN A 328HIS A 342 | DIH A 401 (-3.4A)DIH A 401 (-4.6A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-4.2A)DIH A 401 (-3.1A)DIH A 401 (-3.6A) | 0.71A | 1pwyE-2p4sA:40.6 | 1pwyE-2p4sA:42.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V3Q_E_2DIE290_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 8 / 10 | GLY A 203PHE A 285GLU A 286GLY A 303MET A 304THR A 327ASN A 328HIS A 342 | DIH A 401 (-3.4A)DIH A 401 (-4.6A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-4.2A)DIH A 401 (-3.1A)DIH A 401 (-3.6A) | 0.49A | 1v3qE-2p4sA:41.1 | 1v3qE-2p4sA:42.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_A_ADNA252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.34A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_A_ADNA252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | GLY A 191VAL A 192GLU A 193GLU A 195ARG A 38 | NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)PO4 A 501 (-2.9A) | 1.41A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_A_ADNA252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.26A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_B_ADNB252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 9 | ARG A 101GLY A 191VAL A 192MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.34A | 1vhwB-3of3A:42.61vhwF-3of3A:42.4 | 1vhwB-3of3A:98.771vhwF-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_B_ADNB252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 9 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192MET A 194GLU A 195 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 0.26A | 1vhwB-3of3A:42.61vhwF-3of3A:42.4 | 1vhwB-3of3A:98.771vhwF-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_C_ADNC252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.34A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_C_ADNC252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | GLY A 191VAL A 192GLU A 193GLU A 195ARG A 38 | NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)PO4 A 501 (-2.9A) | 1.41A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_C_ADNC252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.25A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_D_ADND252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | ARG A 38GLY A 191VAL A 192GLU A 193GLU A 195 | PO4 A 501 (-2.9A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A) | 1.41A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_D_ADND252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.33A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_D_ADND252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.26A | 1vhwA-3of3A:42.51vhwD-3of3A:42.5 | 1vhwA-3of3A:98.771vhwD-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_E_ADNE252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | ARG A 38GLY A 191VAL A 192GLU A 193GLU A 195 | PO4 A 501 (-2.9A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A) | 1.41A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_E_ADNE252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.34A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_E_ADNE252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.23A | 1vhwC-3of3A:42.61vhwE-3of3A:42.3 | 1vhwC-3of3A:98.771vhwE-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_F_ADNF252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 10 | ARG A 38GLY A 191VAL A 192GLU A 193GLU A 195 | PO4 A 501 (-2.9A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A) | 1.40A | 1vhwB-3of3A:42.61vhwF-3of3A:42.4 | 1vhwB-3of3A:98.771vhwF-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_F_ADNF252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.34A | 1vhwB-3of3A:42.61vhwF-3of3A:42.4 | 1vhwB-3of3A:98.771vhwF-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1VHW_F_ADNF252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 10 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 0.25A | 1vhwB-3of3A:42.61vhwF-3of3A:42.4 | 1vhwB-3of3A:98.771vhwF-3of3A:98.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z35_A_2FAA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.44A | 1z35A-3of3A:37.8 | 1z35A-3of3A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z35_A_2FAA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 10 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.46A | 1z35A-3of3A:37.8 | 1z35A-3of3A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z37_A_ADNA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 9 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.42A | 1z37A-3of3A:38.1 | 1z37A-3of3A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z37_A_ADNA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 9 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.43A | 1z37A-3of3A:38.1 | 1z37A-3of3A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AC7_A_ADNA1216_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.44A | 2ac7A-3of3A:36.02ac7B-3of3A:36.1 | 2ac7A-3of3A:54.622ac7B-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AC7_A_ADNA1216_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.43A | 2ac7A-3of3A:36.02ac7B-3of3A:36.1 | 2ac7A-3of3A:54.622ac7B-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AC7_B_ADNB1215_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.44A | 2ac7A-3of3A:36.02ac7B-3of3A:36.1 | 2ac7A-3of3A:54.622ac7B-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AC7_B_ADNB1215_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 11 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.43A | 2ac7A-3of3A:36.02ac7B-3of3A:36.1 | 2ac7A-3of3A:54.622ac7B-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E9R_A_ACTA700_0 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 5 / 6 | GLY A 203GLU A 286GLY A 303MET A 304ASN A 328 | DIH A 401 (-3.4A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-3.1A) | 0.53A | 3e9rA-2p4sA:39.9 | 3e9rA-2p4sA:35.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E9R_C_ACTC700_0 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 5 / 6 | GLY A 203GLU A 286GLY A 303MET A 304ASN A 328 | DIH A 401 (-3.4A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-3.1A) | 0.58A | 3e9rC-2p4sA:40.3 | 3e9rC-2p4sA:35.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F8W_A_ADNA300_1 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 9 / 12 | SER A 118TYR A 173ALA A 201GLY A 203GLU A 286GLY A 303MET A 304ASN A 328HIS A 342 | PO4 A 503 (-2.8A)DIH A 401 (-4.7A)PO4 A 503 ( 3.8A)DIH A 401 (-3.4A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-3.1A)DIH A 401 (-3.6A) | 0.39A | 3f8wA-2p4sA:41.5 | 3f8wA-2p4sA:35.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F8W_B_ADNB301_1 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 9 / 12 | SER A 118HIS A 171TYR A 173GLY A 203GLU A 286GLY A 303MET A 304ASN A 328HIS A 342 | PO4 A 503 (-2.8A)DIH A 401 ( 4.0A)DIH A 401 (-4.7A)DIH A 401 (-3.4A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-3.1A)DIH A 401 (-3.6A) | 0.43A | 3f8wB-2p4sA:43.3 | 3f8wB-2p4sA:35.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F8W_C_ADNC302_1 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 9 / 12 | SER A 118HIS A 171TYR A 173ALA A 201GLY A 203GLU A 286GLY A 303MET A 304ASN A 328 | PO4 A 503 (-2.8A)DIH A 401 ( 4.0A)DIH A 401 (-4.7A)PO4 A 503 ( 3.8A)DIH A 401 (-3.4A)DIH A 401 (-2.8A)DIH A 401 (-3.4A)DIH A 401 (-3.5A)DIH A 401 (-3.1A) | 0.36A | 3f8wC-2p4sA:41.3 | 3f8wC-2p4sA:35.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 3 / 3 | MET A 194MET A 180PHE A 173 | DIH A 500 (-3.8A)NoneDIH A 500 (-4.3A) | 1.14A | 3gn8A-3of3A:undetectable | 3gn8A-3of3A:17.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_A_ADNA251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 9 | MET A 78ARG A 101SER A 104VAL A 192GLU A 193MET A 194GLU A 195 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 0.58A | 3u40A-3of3A:36.33u40F-3of3A:34.0 | 3u40A-3of3A:46.123u40F-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_B_ADNB251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 10 | MET A 78ARG A 101SER A 104VAL A 192GLU A 193MET A 194GLU A 195 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 0.50A | 3u40B-3of3A:35.73u40C-3of3A:17.7 | 3u40B-3of3A:46.123u40C-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_C_ADNC251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 12 | GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.44A | 3u40B-3of3A:35.73u40C-3of3A:17.7 | 3u40B-3of3A:46.123u40C-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_C_ADNC251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 12 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.47A | 3u40B-3of3A:35.73u40C-3of3A:17.7 | 3u40B-3of3A:46.123u40C-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_D_ADND251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.41A | 3u40D-3of3A:36.33u40E-3of3A:35.7 | 3u40D-3of3A:46.123u40E-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_D_ADND251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.45A | 3u40D-3of3A:36.33u40E-3of3A:35.7 | 3u40D-3of3A:46.123u40E-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_E_ADNE251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 12 | GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.45A | 3u40D-3of3A:36.33u40E-3of3A:35.7 | 3u40D-3of3A:46.123u40E-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_E_ADNE251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 12 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.45A | 3u40D-3of3A:36.33u40E-3of3A:35.7 | 3u40D-3of3A:46.123u40E-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U40_F_ADNF251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 10 | MET A 78ARG A 101SER A 104VAL A 192GLU A 193MET A 194GLU A 195ASP A 218 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.1A) | 0.70A | 3u40A-3of3A:36.33u40F-3of3A:34.0 | 3u40A-3of3A:46.123u40F-3of3A:46.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UAW_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.43A | 3uawA-3of3A:38.2 | 3uawA-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UAW_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 10 / 11 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A)None | 0.42A | 3uawA-3of3A:38.2 | 3uawA-3of3A:54.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UAY_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.43A | 3uayA-3of3A:37.6 | 3uayA-3of3A:54.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UAY_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 8 / 10 | MET A 78ARG A 101GLY A 106VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.34A | 3uayA-3of3A:37.6 | 3uayA-3of3A:54.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193GLU A 195VAL A 108 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)None | 1.35A | 4d9hA-3of3A:36.3 | 4d9hA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.33A | 4d9hA-3of3A:36.3 | 4d9hA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.48A | 4d9hA-3of3A:36.3 | 4d9hA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | SER A 104GLY A 106VAL A 192GLU A 193SER A 217ASP A 218 | PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.73A | 4d9hA-3of3A:36.3 | 4d9hA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DA6_A_GA2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 9 | GLY A 106VAL A 192MET A 194SER A 217ASP A 218 | DIH A 500 (-4.0A)DIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.95A | 4da6A-3of3A:36.0 | 4da6A-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DA6_A_GA2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 9 | MET A 78SER A 104GLY A 106VAL A 192MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.68A | 4da6A-3of3A:36.0 | 4da6A-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DA7_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 10 | ARG A 101GLY A 191ALA A 170VAL A 192GLU A 193GLU A 195VAL A 108 | PO4 A 501 (-2.8A)NoneDIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)None | 1.27A | 4da7A-3of3A:36.5 | 4da7A-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DA7_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 10 | ARG A 101GLY A 191ALA A 170VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.26A | 4da7A-3of3A:36.5 | 4da7A-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DA7_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 10 | MET A 78ARG A 101GLY A 106ALA A 170VAL A 192GLU A 193MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.45A | 4da7A-3of3A:36.5 | 4da7A-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 106VAL A 192GLU A 193GLU A 195VAL A 108 | PO4 A 501 (-2.8A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)None | 1.45A | 4danA-3of3A:35.6 | 4danA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193GLU A 195VAL A 108 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)None | 1.29A | 4danA-3of3A:35.6 | 4danA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.31A | 4danA-3of3A:35.6 | 4danA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 11 | MET A 78ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A) | 0.54A | 4danA-3of3A:35.6 | 4danA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 7 / 11 | SER A 104GLY A 106VAL A 192GLU A 193MET A 194SER A 217ASP A 218 | PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.73A | 4danA-3of3A:35.6 | 4danA-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 12 | ARG A 101GLY A 191VAL A 192GLU A 193GLU A 195VAL A 108 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-2.9A)None | 1.29A | 4danA-3of3A:35.64danB-3of3A:36.0 | 4danA-3of3A:50.974danB-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 12 | ARG A 101GLY A 191VAL A 192GLU A 193MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.28A | 4danA-3of3A:35.64danB-3of3A:36.0 | 4danA-3of3A:50.974danB-3of3A:50.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 12 | ARG A 101SER A 104GLY A 106VAL A 192GLU A 193MET A 194GLU A 195SER A 217ASP A 218 | PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)DIH A 500 (-3.1A) | 0.67A | 4danA-3of3A:35.64danB-3of3A:36.0 | 4danA-3of3A:50.974danB-3of3A:50.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R29_C_SAMC301_0 (UNCHARACTERIZEDPROTEIN) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 5 / 12 | ALA A 198ARG A 169GLY A 117ALA A 301GLY A 303 | NonePO4 A 503 (-3.9A)PO4 A 503 (-3.4A)NoneDIH A 401 (-3.4A) | 1.27A | 4r29C-2p4sA:undetectable | 4r29C-2p4sA:20.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 9 | ARG A 101GLY A 191ALA A 170VAL A 192MET A 194GLU A 195 | PO4 A 501 (-2.8A)NoneDIH A 500 ( 4.8A)DIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.29A | 5i3cA-3of3A:41.3 | 5i3cA-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 9 | MET A 78ARG A 101SER A 104GLY A 106ALA A 170VAL A 192MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 (-2.8A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 ( 4.8A)DIH A 500 (-4.8A)DIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.32A | 5i3cA-3of3A:41.3 | 5i3cA-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_B_AC2B301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 10 | GLY A 191ALA A 170VAL A 192GLU A 193MET A 194GLU A 195 | NoneDIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.39A | 5i3cB-3of3A:41.7 | 5i3cB-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_B_AC2B301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 9 / 10 | MET A 78SER A 104GLY A 106ALA A 170VAL A 192GLU A 193MET A 194GLU A 195ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)None | 0.27A | 5i3cB-3of3A:41.7 | 5i3cB-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_C_AC2C301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 11 | GLY A 106ALA A 170VAL A 192ASP A 218ILE A 220 | DIH A 500 (-4.0A)DIH A 500 ( 4.8A)DIH A 500 (-4.8A)DIH A 500 (-3.1A)None | 0.94A | 5i3cC-3of3A:41.5 | 5i3cC-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_C_AC2C301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 6 / 11 | GLY A 191ALA A 170VAL A 192GLU A 193MET A 194GLU A 195 | NoneDIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A) | 1.37A | 5i3cC-3of3A:41.5 | 5i3cC-3of3A:80.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I3C_C_AC2C301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 10 / 11 | MET A 78SER A 104GLY A 106ALA A 170VAL A 192GLU A 193MET A 194GLU A 195SER A 217ILE A 220 | DIH A 500 (-3.6A)PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 ( 4.8A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A)DIH A 500 (-2.9A)DIH A 500 (-3.3A)None | 0.40A | 5i3cC-3of3A:41.5 | 5i3cC-3of3A:80.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
2p4s | PURINE NUCLEOSIDEPHOSPHORYLASE (Anophelesgambiae) | 5 / 12 | GLU A 174PRO A 283GLU A 286THR A 327GLY A 203 | NoneNoneDIH A 401 (-2.8A)DIH A 401 (-4.2A)DIH A 401 (-3.4A) | 1.20A | 5xioA-2p4sA:2.4 | 5xioA-2p4sA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZNC_A_QI9A301_0 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3of3 | PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE 1 (Vibriocholerae) | 5 / 9 | SER A 104GLY A 106VAL A 192GLU A 193MET A 194 | PO4 A 501 ( 2.7A)DIH A 500 (-4.0A)DIH A 500 (-4.8A)NoneDIH A 500 (-3.8A) | 0.33A | 5zncA-3of3A:17.6 | 5zncA-3of3A:27.95 |